Status and phase
Conditions
Treatments
About
Exploratory, multi-center, randomised, investigator-blinded, vehicle controlled study using intra-individual comparison involving subjects with acne vulgaris on face to evaluate the efficacy of CD5024 1% cream over a 6-week treatment period compared to its vehicle.
Full description
Study drugs application will be performed once daily, 5 days a week during 6 weeks
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The subject is a male or a female aged from 18 to 35 years old at screening visit.
The subject has a medical diagnosis of acne vulgaris :
2.1 at least 20 (twenty) inflammatory lesions and a maximum of 100 (one hundred) non-inflammatory lesions (nose is excluded for the lesion count) at Baseline
2.2 symmetry of the lesions: No more than twice as many acne lesions on one side as compared to the other side at Baseline
If the subject is a female of childbearing potential, she must agree to use an effective contraceptive method for the duration of the study
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
70 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal